Harnisha Dalwadi

Harnisha Dalwadi is an experienced medical writing professional currently serving as Executive Director of Medical Writing at Summit Therapeutics since February 2023. Previously, Harnisha held positions including Senior Director of Medical Writing at Surrozen and Nektar Therapeutics, as well as Senior Director at Pharmacyclics, an AbbVie Company, where significant contributions included leading the Medical Writing function to ensure the quality of clinical documents for oncology marketing applications and implementing new processes and technologies. Harnisha's career spans various roles such as Regulatory Writer at Amgen and Research Subject Advocate Intern at UCLA, complemented by a robust academic background with a PhD in Pathology and Laboratory Medicine from UCLA and a BS in Molecular Biology from Rensselaer Polytechnic Institute. Notable achievements include receiving the Chairman Award in 2015 and completing an Emerging Leadership Program in 2018.